About Us
Management Team
Dr. Raj (SB) Rajur, PhD, Founder, Chairman and CEO
Dr. Rajur established CreaGen BioSciences, Inc. as an early stage discovery research service provider and it has now evolved into a well-known collaborative research organization. Under his leadership, CreaGen collaborates with a number of multinational pharmaceutical and biotech companies. more...


Dr Rajur holds a PhD degree in synthetic and organic chemistry and has enjoyed a distinguished career in the academic community and the pharmaceutical industry with a broad range of experience in medicinal chemistry and drug discovery. He has authored more than 25 papers in peer-reviewed journals and holds three US patents.

Dr. Rajur's academic career includes appointments at the Southwestern Medical Center in Dallas, Boston College, Northeastern University, Massachusetts General Hospital and Harvard Medical School. In the industrial sector, he has held scientific and managerial positions at ArQule and Millipore Corporations. At ArQule, Dr. Rajur supervised collaborations with Bayer, Pfizer and Amersham Pharmacia Biosciences. Dr. Rajur also significantly contributed to ArQule's internal drug discovery programs, specifically the ion channel, kinase and GPCR programs. Products co-developed by Dr. Rajur have been used in drug discovery efforts at Clonetech Laboratories in Palo Alto, CA.

Dr. Rajur's expertise is with small molecule drug discovery, specifically targeted towards cancer and anti-infective therapeutics and the development of prodrug pharmaceuticals.

Dr. Rajur serves as the reviewer for the ACS Journal of Pharmaceutical Sciences and presently is Councilor and Program Chair for the Medicinal Chemistry Division of the Northeastern Section of the American Chemical Society.
Hwa-Ok Kim, PhD, Director of Chemistry
Dr. Kim received his PhD degree from New Mexico State University and then entered his postdoctoral appointment at Marion Merrell Dow. Dr. Kim served as Director of Chemistry at Aurigene Discovery Technologies, where he directed all global partnered chemistry programs. Prior to that, as Project Leader at Molecumetics, he managed five partnered projects, company internal projects, and High Throughput Organic Synthesis (Automation Synthesis) for collaborations with more than $10M revenue. Dr. Kim has authored more than 40 technical articles and books and holds ten US Patents.
Financial Advisor
Mr. Vimal Raheja, MBA, CPA
Mr. Raheja received his BA degree from the University of Massachusetts, Amherst, MA, his MBA degree from Suffolk University, Boston, MA, and his MSA degree from Bentley College, Waltham, MA. He is a member of the American Institute of Certified Public Accountants and also a member of the Massachusetts Society of Certified Public Accountants.
 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.